Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Breast Cancer Research : BCR|November 6, 2007
Live or let die: oestrogen regulation of survival signalling in endocrine responseAlison J Butt, Robert L Sutherland, Elizabeth A MusgroveJournal of Mammary Gland Biology and Neoplasia|April 15, 2004
Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout miceElizabeth A Musgrove, Elizabeth A Davison, Christopher J OrmandyBMC Cancer|January 22, 2014
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cellsJian Kang, C Marcelo Sergio, Robert L Sutherland, et al.Cancer Research|May 31, 2002
Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogensJason S Carroll, Alexander Swarbrick, Elizabeth A Musgrove, et al.Endocrine-Related Cancer|August 23, 2005
Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin EAlison J Butt, Catriona M McNeil, Elizabeth A Musgrove, et al.Cell Cycle (Georgetown, Tex.)|January 18, 2013
Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Robert L Sutherland, et al.Histology and Histopathology|January 9, 2009
Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancerSarah J Zardawi, Sandra A O'Toole, Robert L Sutherland, et al.Journal of Cellular Biochemistry|November 4, 2005
Cell cycle control in breast cancer cellsC Elizabeth Caldon, Roger J Daly, Robert L Sutherland, et al.Nature Reviews. Cancer|July 8, 2011
Cyclin D as a therapeutic target in cancerElizabeth A Musgrove, C Elizabeth Caldon, Jane Barraclough, et al.Molecular and Cellular Biology|September 1, 2010
Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cellsDavid R Croucher, Danny Rickwood, Carole M Tactacan, et al.Pageof 8